Core Laboratories N.V.

NYSE:CLB

Oil & Gas Equipment & Services

Energy
$8.45 +1.01%

+$0.12 today

Market cap
$387.21M
Beta
0.99
P/E (TTM)
18.3
EPS (TTM)
$0.63
Dividend yield
0.35%
52W Low $9.72High $20.36

Volume 0.52M

Average 0.49M

CLB Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Core Laboratories N.V.NYSE: CLB

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation grows, but more slowly than its trailing trend

Q1 FY2026 stock-based compensation of $5.03M rose 21.0% year over year, behind the +347.7% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 351.7% from the prior quarter. Over 3 fiscal years it compounded at -2.7% a year.

Context

  • Stock-based compensation amounted to 1.4% of revenue in FY2025, up 0.6 pp from a year earlier.
  • Stock-based compensation increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +21.0% toward the trailing-twelve-month pace of +347.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$5.03M+351.7% QoQ
Last fiscal yearDec 2025
$7.14M+90.1% YoY
LTMMar 2026
$7.47M+347.7% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+21.0%——
1 year+90.1%——
3-year CAGR-2.7%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
7.14M USD
Year-over-year change
+90.1%
4-year CAGR
-21.8%

Stock-Based Compensation vs competitors

How CLB compares with its peers on the latest reported figures

  • Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +347.7% is the highest of 9, against a peer median of -3.6%.
  • Stock-based compensation amounts to 1.4% of revenue for CLB, versus a peer median of 1.0%.
CLB Competitors
Stock-Based Compensation for CLB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SOCSable Offshore Corp.LTM Mar 2026$36.61M USD+26.4%—2880.7%
NBRNabors Industries Ltd.LTM Mar 2026$23.61M USD+43.3%+13.9%0.7%
BORRBorr Drilling LimitedLTM Mar 2026$10.5M USD-1.9%+63.2%1.0%
PDSPrecision Drilling CorporationLTM Mar 2026CA$8.98M CAD-37.9%—0.5%
VTSVitesse Energy, Inc.LTM Mar 2026$8.5M USD-5.3%—3.1%
CLBCore Laboratories N.V.LTM Mar 2026$7.47M USD+347.7%-2.7%1.4%
TXOTXO Partners, L.P.LTM Mar 2026$7.04M USD——2.0%
GRNTGranite Ridge Resources, IncLTM Mar 2026$4.44M USD+140.0%—1.0%
CAPLCrossAmerica Partners LPLTM Mar 2026$1.24M USD-41.3%-6.9%0.0%
HPKHighPeak Energy, Inc.LTM Mar 2026$1.13M USD-87.6%—0.1%
Peer median (excluding CLB) —-3.6%+13.9%1.0%

Competitors are the stored peer set for CLB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income20.22M19.66M37.03M32.15M31.8M
Depreciation & Amortization18.52M17.16M15.78M14.95M14.65M
Deferred Income Tax6.01M433K(10.81M)674K(4.74M)
Stock-Based Compensation19.09M7.76M13.97M3.76M7.14M
Change in Working Capital(24.25M)(25.02M)(28.77M)7.88M(5.57M)
Accounts Receivables(13.52M)(10.08M)(2.62M)(3.61M)(4.95M)
Inventory(4.55M)(14.86M)(12.98M)9.37M2.64M
Accounts Payables6.57M15.37M(12.88M)519K477K
Other Working Capital(12.75M)(15.46M)(300K)1.61M(3.73M)
Other Non-Cash Items(3.01M)4.97M(2.41M)(3.03M)(6.11M)
Operating Cash Flow36.58M24.96M24.79M56.39M37.18M
Capital Expenditures(13.54M)(10.22M)(10.58M)(13.03M)(14.59M)
Acquisitions (Net)873K240K00(1.24M)
Purchases of Investments13.54M0000
Sales of Investments726K0000
Other Investing Activities(11.82M)6.12M3.93M6.63M13.6M
Investing Cash Flow(10.22M)(3.86M)(6.65M)(6.39M)(2.23M)
Debt Repayment(71M)(15M)(9M)(38M)(16.71M)
Common Stock Issued60M0000
Common Stock Repurchased(8.26M)(3.9M)(2.2M)(5.31M)(12.43M)
Dividends Paid(1.83M)(1.85M)(1.87M)(1.88M)(1.87M)
Other Financing Activities(1.37M)(2.62M)(5.38M)(775K)(254K)
Financing Cash Flow(22.46M)(23.38M)(18.45M)(45.96M)(31.26M)
Effect of Forex Changes00000
Net Change in Cash3.9M(2.28M)(308K)4.04M3.69M
Free Cash Flow23.04M14.74M14.21M43.36M22.59M

Core Laboratories N.V.

NYSE:CLB

Intrinsic Alpha fair value

Locked

Current Price

$8.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.